Blinded

Torsades de Pointes drug cardiotoxicity human ventricular action potential in silico drug trials ion channels

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2019
Historique:
received: 25 07 2019
accepted: 16 12 2019
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

Torsades de Pointes (TdP) is a type of ventricular arrhythmia which could be observed as an unwanted drug-induced cardiac side effect, and it is associated with repolarization abnormalities in single cells. The pharmacological evaluations of TdP risk in previous years mainly focused on the hERG channel due to its vital role in the repolarization of cardiomyocytes. However, only considering drug effects on hERG led to false positive predictions since the drug action on other ion channels can also have crucial regulatory effects on repolarization. To address the limitation of only evaluating hERG, the Comprehensive in Vitro Proarrhythmia Assay initiative has proposed to systematically integrate drug effects on multiple ion channels into

Identifiants

pubmed: 32082155
doi: 10.3389/fphar.2019.01643
pmc: PMC7003137
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1643

Subventions

Organisme : British Heart Foundation
ID : FS/17/22/32644
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Zhou, Qu, Passini, Bueno-Orovio, Liu, Vargas and Rodriguez.

Références

Biophys J. 2011 Dec 21;101(12):2892-902
pubmed: 22208187
Br J Pharmacol. 2012 May;166(2):557-68
pubmed: 22013922
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):868-77
pubmed: 22895603
J Membr Biol. 2008 Apr;222(3):151-66
pubmed: 18566732
J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):146-53
pubmed: 15936218
Br J Pharmacol. 2009 Mar;156(6):920-32
pubmed: 19222480
Front Pharmacol. 2015 Mar 24;6:59
pubmed: 25852560
J Mol Cell Cardiol. 2015 Oct;87:271-82
pubmed: 26859003
Circ Arrhythm Electrophysiol. 2017 Feb;10(2):e004628
pubmed: 28202629
J Cardiovasc Pharmacol. 2011 Jan;57(1):79-85
pubmed: 20980921
Pacing Clin Electrophysiol. 2002 Nov;25(11):1612-5
pubmed: 12494620
Front Physiol. 2019 Mar 29;10:350
pubmed: 30984029
Circulation. 2008 Sep 2;118(10):981-2
pubmed: 18765386
J Pharmacol Exp Ther. 1996 Feb;276(2):637-46
pubmed: 8632331
Circ Res. 2011 Jan 7;108(1):113-28
pubmed: 21212393
J Mol Cell Cardiol. 2016 Oct;99:151-161
pubmed: 27545042
Clin Pharmacol Ther. 2016 Oct;100(4):371-9
pubmed: 26950176
Circ Res. 1988 Mar;62(3):563-71
pubmed: 2449297
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:251-62
pubmed: 27060526
Am Heart J. 2014 Mar;167(3):292-300
pubmed: 24576511
Circ Res. 1989 May;64(5):977-90
pubmed: 2468430
Circulation. 2013 Feb 5;127(5):575-84
pubmed: 23271797
Cardiovasc Res. 1993 Dec;27(12):2229-37
pubmed: 8313433
J Mol Cell Cardiol. 2011 May;50(5):863-71
pubmed: 21345340
Am J Cardiol. 2000 Nov 2;86(9A):111K-115K
pubmed: 11084109
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1594-605
pubmed: 19767530
Cardiovasc Res. 2011 Jul 1;91(1):53-61
pubmed: 21300721
J Cardiovasc Electrophysiol. 1999 Aug;10(8):1124-52
pubmed: 10466495
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182
pubmed: 28329228
Heart Rhythm. 2011 Nov;8(11):1756-7
pubmed: 21708111
Clin Pharmacokinet. 1984 Mar-Apr;9(2):136-56
pubmed: 6370540
PLoS One. 2014 Jan 10;9(1):e84595
pubmed: 24427289
J Cardiovasc Electrophysiol. 1996 Nov;7(11):1074-81
pubmed: 8930739
J Physiol. 2016 Dec 1;594(23):6865-6878
pubmed: 26830210
Eur J Pharm Sci. 2009 Jan 31;36(1):62-77
pubmed: 19061955
Sci Transl Med. 2011 Aug 31;3(98):98ra83
pubmed: 21885405
Front Pharmacol. 2017 Nov 14;8:816
pubmed: 29184497
Cardiovasc Res. 2003 Apr 1;58(1):32-45
pubmed: 12667944
J Cardiovasc Pharmacol. 2004 Mar;43(3):369-79
pubmed: 15076220
Sci Rep. 2019 Nov 14;9(1):16803
pubmed: 31728039
Front Physiol. 2017 May 05;8:278
pubmed: 28529489
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):2983-8
pubmed: 19218447
Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H338-H353
pubmed: 28550171
Jpn Circ J. 1993 Jun;57(6):543-52
pubmed: 8341001
PLoS One. 2013;8(1):e54635
pubmed: 23355885
Heart Rhythm. 2010 Dec;7(12):1891-9
pubmed: 20868774
Heart Rhythm. 2012 Jun;9(6):953-60
pubmed: 22245792
J Pharmacol Toxicol Methods. 2020 Jan - Feb;101:106654
pubmed: 31730936
Br J Pharmacol. 2006 Dec;149(7):845-60
pubmed: 17031389
J Pharmacol Toxicol Methods. 2004 Sep-Oct;50(2):93-101
pubmed: 15385083
J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:15-20
pubmed: 27282641
Pacing Clin Electrophysiol. 1998 May;21(5):1029-34
pubmed: 9604234
Front Physiol. 2017 Sep 12;8:668
pubmed: 28955244
Basic Res Cardiol. 2005 Jul;100(4):365-71
pubmed: 15944809
PLoS One. 2017 Dec 7;12(12):e0188867
pubmed: 29216239
Heart Rhythm. 2005 Nov;2(2 Suppl):S9-15
pubmed: 16253930
J Mol Cell Cardiol. 2016 Jul;96:72-81
pubmed: 26385634
Br J Pharmacol. 2019 Oct;176(19):3819-3833
pubmed: 31271649
J Pharm Pharmacol. 1984 Jun;36(6):366-72
pubmed: 6146666
PLoS Comput Biol. 2011 May;7(5):e1002061
pubmed: 21637795
J Biomol Screen. 2016 Jan;21(1):1-11
pubmed: 26170255
J Am Coll Cardiol. 1989 Jul;14(1):172-84
pubmed: 2661626
Prog Biophys Mol Biol. 2016 Jan;120(1-3):236-48
pubmed: 26850675
Can J Cardiol. 2008 Aug;24(8):640-2
pubmed: 18685745
J Physiol. 2014 Mar 15;592(6):1181-97
pubmed: 24421356
Biophys J. 1995 Mar;68(3):949-64
pubmed: 7538806
Circ Res. 1993 Jan;72(1):75-83
pubmed: 8417848
Sci Rep. 2013;3:2100
pubmed: 23812503
Heart Rhythm. 2015 May;12(5):1088-96
pubmed: 25623180
J Pharmacol Toxicol Methods. 2010 Mar-Apr;61(2):178-91
pubmed: 20172036
Hum Psychopharmacol. 2012 Jan;27(1):39-42
pubmed: 22144033
Pharmacol Ther. 2011 Feb;129(2):109-19
pubmed: 20807552

Auteurs

Xin Zhou (X)

Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, United Kingdom.

Yusheng Qu (Y)

SPARC, Amgen Research, Amgen Inc., Thousand Oaks, CA, United States.

Elisa Passini (E)

Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, United Kingdom.

Alfonso Bueno-Orovio (A)

Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, United Kingdom.

Yang Liu (Y)

GAU, Amgen Research, Amgen Inc., South San Francisco, CA, United States.

Hugo M Vargas (HM)

SPARC, Amgen Research, Amgen Inc., Thousand Oaks, CA, United States.

Blanca Rodriguez (B)

Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, United Kingdom.

Classifications MeSH